Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective

Based on clinical and experimental evidence, metabolic syndrome (MetS) and type 2 diabetes (T2D) are considered risk factors for chronic cerebral hypoperfusion (CCH) and neurodegeneration. Scientific evidence suggests that protein misfolding is a potential mechanism that explains how CCH can lead to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordet, Sofía, Luaces, Juan Pablo, Herrera, Maria Ines, Gonzalez, Liliana Mirta, Kobiec, Tamara, Perez-Lloret, Santiago, Otero-Losada, Matilde, Capani, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463751/
https://www.ncbi.nlm.nih.gov/pubmed/37650104
http://dx.doi.org/10.3389/fnins.2023.1215041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463751/
https://www.ncbi.nlm.nih.gov/pubmed/37650104
http://dx.doi.org/10.3389/fnins.2023.1215041

Ejemplares similares